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The conversion of proteins into structured fibrillar aggre-
gates is a central problem in protein chemistry, biotechnol-
ogy, biology and medicine. It is generally accepted that
aggregation takes place from partially structured states of
proteins. However, the role of the residual structure
present in such conformational states is not yet under-
stood. In particular, it is not yet clear as to whether the a-
helical structure represents a productive or counteracting
structural element for protein aggregation. We have
addressed this issue by studying the aggregation of pH-
unfolded HypF-N. It has previously been shown that the
two native a-helices of HypF-N retain a partial a-helical
structure in the pH-unfolded state and that these regions
are also involved in the formation of the cross-b structure
of the aggregates. We have introduced mutations in
such stretches of the sequence, with the aim of increasing
the a-helical structure in the key regions of the pH-
unfolded state, while minimizing the changes of other
factors known to influence protein aggregation, such as
hydrophobicity, b-Sheet propensity, etc. The resulting
HypF-N mutants have higher contents of a-helical struc-
ture at the site(s) of mutation in their pH-unfolded states,
but such an increase does not correlate with a change of
aggregation rate. The results suggest that stabilisation of
a-helical structure in amyloidogenic regions of the
sequence of highly dynamic states does not have remark-
able effects on the rate of protein aggregation from such
conformational states. Comparison with other protein
systems indicate that the effect of increasing a-helical pro-
pensity can vary if the stabilised helices are in non-amyloi-
dogenic stretches of initially unstructured peptides
(accelerating effect), in amyloidogenic stretches of initially
unstructured peptides (no effect) or in amyloidogenic
stretches of initially stable helices (decelerating effect).
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Introduction
Proteins and peptides have a generic propensity to form well-
organised fibrillar aggregates characterised by an extended
cross-b structure, generally referred to as amyloid-like fibrils
(Dobson, 1999; Dobson and Stefani, 2003; Uversky and
Fink, 2004; Chiti and Dobson, 2006). From a physicochem-
ical perspective, this process represents an essential feature
of the behaviour of polypeptide chains that needs to be fully
understood for a thorough characterisation of the nature of
proteins (Jahn and Radford, 2008). From a more biological
perspective, formation of amyloid fibrils, or intracellular
inclusions with structurally related characteristics, is associ-
ated with a large number of pathological conditions in
humans (Chiti and Dobson, 2006). It is also a major problem
in biotechnology as the large-scale expression of proteins
potentially interesting to the market often results in their self-
assembly in inclusion bodies with amyloid-like structural
features (Ventura and Villaverde, 2006).
It is well accepted that the process of amyloid fibril for-
mation by normally globular proteins requires a partial or
global unfolding of the native structure across the major free-
energy barrier for unfolding or, alternatively, structural and
transient fluctuations from the native state ensemble (Chiti
and Dobson, 2009). Several studies have shown that aggrega-
tion of highly flexible, partially folded states is promoted by
regions of the sequence with a high hydrophobicity and high
propensity to form b-sheet structure, resulting in mathemat-
ical algorithms able to predict the aggregation-promoting
regions in a protein from the knowledge of its sequence
(Fernandez-Escamilla et al., 2004; Yoon and Welsh, 2004;
Pawar et al., 2005; Tartaglia et al., 2005; Trovato et al.,
2006; Galzitskaya et al., 2006; Conchillo-Sole´ et al., 2007;
Maurer-Stroh et al., 2010). It is not clear, however, if the
residual structure present in the aggregation-competent state
plays an important role in the process. While it is widely
recognised that an efficient mechanism to neutralise the amy-
loidogenic potential of aggregation-promoting regions is to
promote their folding into a stable and persistent structure,
such as that of the native state of a globular protein (Dobson,
1999; Uversky and Fink, 2004; Monsellier and Chiti, 2007;
Tzotzos and Doig, 2010), it is still unclear as to whether the
flexible structure present in partially folded states of proteins
plays a role in the process of aggregation from such states.
Similarly, it is not clear as to whether the formation of struc-
ture in intrinsically disordered proteins plays a role in the
process of amyloid formation by such systems.
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In particular, the results describing the role of a-helical
structure are contradictory. The formation of amyloid fibrils
by the 40- and 42-residue forms of the amyloid b (Ab)
peptide has been shown to be preceded by the formation of
oligomeric species with a-helical structure, leading to the
conclusion that an a-helical containing oligomer is an
on-pathway species necessary to form fibrils (Kirkitadze
et al., 2001). Such a hypothesis was reinforced by the finding
that small-to-moderate concentrations of the a-helical
inducer 2,2,2-trifluoroethanol (TFE) is able to shorten the lag
phase of amyloid fibril formation by the Ab peptide (Fezoui
and Teplow, 2002). Another widely studied intrinsically dis-
ordered peptide, namely the islet amyloid polypeptide
(IAPP), was shown to form transiently a-helical structure
and aggregate more rapidly in the presence of model phos-
pholipid membranes (Knight et al., 2006; Ling et al., 2009).
Fibril formation by IAPP was also found to be accelerated in
the presence of small concentrations of hexafluoroisopropa-
nol (Padrick and Miranker, 2002; Abedini and Raleigh,
2005). In contrast to these findings, other reports have shown
that the increase in the a-helical propensity of specific
regions of the sequence by protein engineering results in a
significant deceleration of the process of amyloid fibril for-
mation (Villegas et al., 2000; Pa¨ivio¨ et al., 2004).
None of such studies can, however, directly address this
issue: in the absence of appropriate kinetic tests, the early
appearance of oligomers with a-helical structure is not a
direct demonstration that the oligomers are on-pathway and
that the a-helical structure contained in such oligomers is a
productive type of structure for the formation of the fibrils
(Abedini and Raleigh, 2009). The addition of TFE causes
dramatic changes to the property of the solution, modifies the
dynamics of the polypeptide chain and stabilises hydrogen
bonds more generally (not only those of the a-helical struc-
ture, but also those of the cross-b structure of the fibrils). It
is thus difficult to correlate the TFE-induced acceleration of
aggregation to the requirement of forming a-helical structure
during aggregation. On the other hand, mutations used to
stabilise the a-helical structure often involve dramatic
changes of the hydrophobicity, b-sheet propensity and
charge of the sequence at the site of mutation. Since such
factors are demonstrated to be important determinants of the
aggregation rate of an unstructured polypeptide chain,
changes of the aggregation rate resulting from such mutations
cannot be attributed unambiguously to the induced changes
of the a-helical structure.
In this work we have attempted to circumvent the problem
using the N-terminal domain of the Escherichia coli protein
HypF (HypF-N). This protein domain folds with a well-
characterised mechanism (Calloni et al., 2003) and was
shown to form amyloid-like fibrils structurally, morphologi-
cally and tinctorially indistinguishable from those associated
with disease (Chiti et al., 2001; Relini et al., 2004; Marcon
et al., 2005). It was also shown to form amyloid-like protofi-
brils positive to thioflavin T (ThT) and containing b-sheet at
pH values lower than 2.3 and at ionic strength values higher
than 100 mM (Campioni et al., 2008; Calloni et al., 2008;
Campioni et al., 2010). Under such conditions of low pH
HypF-N retains, in the acid-unfolded, monomeric state popu-
lated before aggregation, a partially folded conformation,
where the two regions of the sequence adopting a-helical
structure in the native state (residues 22–32 and 55–63) are
not completely unfolded, as monitored with far-UV circular
dichroism (CD) and nuclear magnetic resonance (NMR)
(Campioni et al., 2008; Calloni et al., 2008). Importantly,
both regions of the sequence have been shown to play an
important role in the process of amyloid-like protofibril for-
mation, as deduced from the ability of mutations located in
these two regions to significantly affect such a process
(Calloni et al., 2008). In addition, structural information indi-
cates that such regions form the structural core of the result-
ing aggregates, meaning that most, if not all, of their
residues form the b-sheet structure stabilising the aggregates
(Campioni et al., 2010). These findings make HypF-N an
ideal system to explore the role of a-helical structure in the
process of amyloid fibril formation. Indeed, the regions of
the sequence adopting an a-helical conformation in the
native state (residues 22232 and 55263) not just partially
retain a-helical structure in the partially folded acid-
denatured state, but are also involved in the process of
aggregation of such a conformational state into amyloid-like
protofibrils, thus encouraging an investigation of the impor-
tance of the a-helical structure in the process of aggregation.
For this purpose, we have introduced specific mutations
that increase significantly the a-helical propensity of these
two regions of the sequence, while minimising the changes
of the other factors affecting aggregation and, as a
consequence, minimising the changes to the intrinsic
(sequence-based) propensity to form amyloid fibrils of the
acid-denatured state. We will show that the resulting HypF-N
variants are characterised by a higher amount of a-helical
structure at the sites of mutation in the acid-unfolded state,
but aggregate with a rate similar to that of the wild-type
protein, ruling out that formation or stabilisation of a-helical
structure in a highly dynamic state has a fundamental role in
the process of amyloid formation.
Materials and methods
HypF-N mutants production, expression and purification
All the HypF-N mutants were produced using the
QuikChange site-directed mutagenesis kit (Stratagene,
La Jolla, CA, USA) and DNA sequencing was used to
ensure the presence of the desired mutation(s). The genes for
wild-type and mutant HypF-N were cloned in a modified
pQE30-Xa plasmid (Qiagen S.p.A, Milano, Italy), in which
the DNA stretch coding for the factor Xa cleavage site was
changed into a sequence coding for the thrombin cleavage
site (pQE30-Th) (Campioni et al., 2008). The protein was
expressed in E. coli XL1-Blue cells transformed with the
pQE30-Th plasmid and purified as described previously
(Campioni et al., 2008). Protein purity was assessed by
SDS-PAGE and was found to be .95%. Protein concen-
tration was assessed by optical absorption (e280 ¼ 12,490
M21 cm21) and stock solutions were stored at 2208C in
5 mM acetate, 2 mM dithiothreitol (DTT), pH 5.5.
Acid-induced unfolding of HypF-N mutants
Buffer solutions were prepared at various pH values ranging
from 7.0 to 1.0. For pH values of 5.7–7.0, 3.9–5.1 and 2.1–
3.7, solutions containing 25 mM 3,3-dimethylglutarate,
50 mM acetate and 50 mM citrate were used, respectively.
pH values ,2.0 were obtained by adding different amounts
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of trifluoroacetic acid (TFA). Since a given compound can
buffer the pH only in a limited range of pH (pKa–1 , pH ,
pKa þ 1), it was necessary to use different compounds to
cover the pH range under investigation (1.0–7.0). All sol-
utions contained 2 mM b-Mercaptoethanol to maintain the
three cysteine residues in a reduced form, and a total ionic
strength of 50 mM was achieved for all solutions by adding
different amounts of NaCl. The samples containing 19 and
1.9 mM protein were then subjected to far-UV CD and intrin-
sic fluorescence analyses, respectively. For this purpose, a
Jasco J-810 spectropolarimeter (Tokyo, Japan) equipped with
a thermostated cell holder attached to a Thermo Haake C25P
water bath (Karlsruhe, Germany) and a Perkin-Elmer LS 55
spectrofluorimeter (Wellesley, MA, USA) equipped with a
thermostated cell holder attached to a Haake F8 water bath
(Karlsruhe, Germany) were used, respectively. Plots of wave-
length of maximum fluorescence emission (lmax) and mean
residue ellipticity at 222 nm ([u]222) were fitted to a sigmoi-
dal function of the form:
y ¼ ðq1 þ m1  pHÞ þ ðq2 þ m2  pHÞ  f10nðpHpKaÞ=
½1 þ 10nðpHpKaÞg
ð1Þ
where q1, q2, m1 and m2 are the intercept (q) and angular
coefficient (m) values of the post- and pre-transition base-
lines, respectively; n is the number of protons involved in the
transition; pKa refers to the pKa value(s) of the residues
titrated in the transition. m1 and m2 values were constrained
to 0 in our analysis.
Urea-induced unfolding of HypF-N mutants
For each HypF-N variant, 18 samples containing 19 mM
HypF-N, 25 mM 3,3-dimethylglutarate, 2 mM DTT, pH 7.0
and different concentrations of urea, ranging from 0 to
8.0 M, were prepared. Other 18 samples containing 19 mM
HypF-N, 20 mM TFA, 30 mM NaCl, 2 mM DTT, pH 1.7
and different concentrations of urea, ranging from 0 to
8.0 M, were prepared. All samples were equilibrated for 2 h
at 258C and subjected to far-UV CD analysis. The unfolding
parameters DGH2O and m, were obtained from plots of [u]222
versus urea concentration by a non-linear regression analysis
of the data using the following equation (Santoro and Bolen,
1988):
½u222 ¼½ðYN þ mN½ureaÞ þ ðYU þ mU½ureaÞ  expðDGH2O
þ m½ureaÞ=RT =½1 þ expðDGH2O þ m½ureaÞ=RT 
ð2Þ
where [u]222 is the mean residue ellipticity, YN and YU rep-
resent the intercepts and mN and mU the slopes of the pre-
transition (native protein) and post-transition (unfolded
protein) baselines, respectively. Thus, fits of urea-induced
equilibrium unfolding data to equation (2) yield values for
DGH2O and m. DGH2O is the standard free-energy changes for
the unfolding transition in the absence of denaturant, and
m is the denaturant susceptibility parameter that describes the
dependence of DGH2O on denaturant concentration. The ratio
between the DGH2O and m values provides the mid-point of
urea-induced unfolding (Cm).
Far-UV CD
Far-UV CD spectra were acquired at 258C for all the
HypF-N variants using solutions containing 19 mM protein,
20 mM TFA, 30 mM NaCl, 2 mM DTT, pH 1.7. A 1-mm
path-length cell and a Jasco J-810 spectropolarimeter
(Tokyo, Japan) equipped with a thermostated cell holder
attached to a Thermo Haake C25P water bath (Karlsruhe,
Germany) were used. The a-helical content was estimated
from the mean residue ellipticity at 222 ([u]222) following
the equation (Morrow et al., 2002):
%a helix ¼ ð½u222 þ 3000Þ=39000 ð3Þ
The increase in percent a-helical content at the site of
mutation (I-aMUT) was obtained using:
IaMUT ¼ ½ð%a helixÞMUT ð%a helixÞWT
 Na=NTOT ð4Þ
where (% a-helix)MUT and (% a-helix)WT are the percen-
tages of a-helical structure of the overall mutated and wild-
type sequences, respectively; Na and NTOT are the number of
residues in the mutated helix and overall sequence, respect-
ively. According to this scale, a I-aMUT value of 25% does
not mean that the a-helical content of the mutated helix has
increased by 25% relative to the wild-type helix, but that the
a-helical content of the mutated helix has increased by 25%
in a scale from 0 (no helix) to 100% (fully formed helix),
independently of the initial value of the wild-type helix.
Intrinsic fluorescence
All samples, initially containing 19 mM HypF-N, 20 mM
TFA, 30 mM NaCl, 2 mM DTT and pH 1.7 were diluted
10-fold in the same solution conditions immediately before
the measurements. Final protein concentration was 1.9 mM.
Intrinsic fluorescence emission spectra were acquired at 258C
from 300 to 400 nm with excitation at 280 nm. A
Perkin-Elmer LS 55 spectrofluorimeter (Wellesley, MA,
USA), equipped with a thermostated cell holder attached to a
Haake F8 water bath (Karlsruhe, Germany), and a 2-mm 
10-mm path-length quartz cell, were used.
ANS fluorescence
ANS fluorescence spectra were acquired at 258C for all the
HypF-N variants using solutions containing 5 mM protein,
20 mM ANS, 20 mM TFA, 30 mM NaCl, 2 mM DTT and pH
1.7. 8-Anilinonaphthalene-1-sulphonate (ANS) was purchased
from Sigma-Aldrich. Fluorescence spectra were acquired at
258C immediately after dilution of the protein variants into
the conditions of analysis. The same cell and equipment
described above, with an excitation wavelength of 380 nm
and an emission range from 400 to 600 nm, were used. A
spectrum was also acquired in the absence of protein and sub-
tracted from all the spectra acquired in the presence of
protein. All the spectra are reported according to this subtrac-
tion procedure.
Dynamic light scattering
HypF-N and its variants were incubated for 30 min at a
protein concentration of 38 mM in 20 mM TFA, 30 mM
NaCl, 2 mM DTT and pH 1.7. In each case the protein stock
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solution was filtered with a 20-nm syringe filter (Whatman,
Maidstone, UK) immediately before sample preparation.
Buffer solutions were also filtered. The dynamic light-
scattering (DLS) measurements were performed at 258C
using the Malvern Zetasizer Nano S instrument (Malvern,
Worcestershire, UK), equipped with a Peltier temperature
controller. Disposable polystyrene cuvettes having a 1-cm
path length were used. Every sample was measured three
times and the average distributions are reported. For each
protein variant, the average and the standard error values of
the sizes corresponding to the peak of interest in each of
these three distributions were used as a measure of the appar-
ent hydrodynamic diameter and associated experimental
error, respectively.
ThT fluorescence
Aggregation of each HypF-N variant was initiated by incu-
bating the protein, at a concentration of 48 mM, in 20 mM
TFA, 330 mM NaCl, 2 mM DTT, pH 1.7, 258C. At regular
time interval aliquots of 60 ml were mixed with 440 ml of
25 mM phosphate buffer, pH 6.0, containing 25 mM ThT and
the resulting fluorescence was measured using a
Perkin-Elmer LS 55 spectrofluorimeter (Wellesley, MA,
USA) equipped with a thermostated cell holder attached to a
Haake F8 water bath (Karlsruhe, Germany) at excitation
and emission wavelengths of 440 and 485 nm, respectively.
A 2  10-mm path-length quartz cell was used. Plots of ThT
fluorescence against time were fitted to a single exponential
function:
FðtÞ ¼ F1 þ DF  expðkaggtÞ ð5Þ
where F(t) represents the fluorescence as a function of time,
DF is the amplitude of the observed change in ThT fluor-
escence, F1 is the fluorescence at the plateau and kagg is the
aggregation rate constant. The analysis yielded the rate con-
stant for aggregation (kagg) for each HypF-N variant.
Atomic force microscopy
All HypF-N variants were incubated at a concentration of
48 mM for 2 h in 20 mM TFA, 330 mM NaCl, 2 mM DTT,
pH 1.7, 258C. Then 5 mL aliquots of 100-fold diluted
samples were immediately deposited on a freshly cleaved
mica substrate and dried under a gentle nitrogen flux.
Non-contact AC mode atomic force microscopy (AFM)
images were acquired in air using a PicoSPM microscope
equipped with an AC-mode controller (Molecular Imaging,
Phoenix, AZ). Rectangular non-contact cantilever (model
NSG01, NT-MDT Moscow, Russia), with typical resonance
frequency of 150 Khz, were used. Oligomer sizes were
measured from the height in cross section of the topographic
AFM images.
Results
Design of HypF-N variants with increased a-helical
propensity at low pH
HypF-N contains two a-Helices in the native state, encom-
passing residues 22–32 and 55–63 (Fig. 1) (Rosano et al.,
2002). These two regions of the sequence were shown to
maintain, at least partially, their a-helical conformation in
the monomeric acid-unfolded state and were shown to play a
relevant role in the conversion of acid-denatured HypF-N
into oligomers with b-Sheet structure and ThT-binding
(Calloni et al., 2008; Campioni et al., 2010). Mutations
aimed at increasing the a-helical content of unfolded
HypF-N at pH 1.7, without increasing its intrinsic aggrega-
tion propensity, were designed using the sequence-based
AGADIR algorithm (Mun˜oz and Serrano, 1994) in conjunc-
tion with the ZYGGREGATOR (Tartaglia et al., 2008),
AGGRESCAN (Conchillo-Sole´ et al., 2007) and PASTA
(Trovato et al., 2006) algorithms.
As shown by the a-helical propensity profiles generated
by the AGADIR algorithm, the mutation Q31R, involving
the first a-Helix, and the mutations Q60R and F57L/Q60R,
involving the second a-Helix, are predicted to induce
remarkable increases of the a-helical propensity at the corre-
sponding sites of mutation (Fig. 2A). In contrast, all three
mutations are predicted to cause very small changes, if any,
of the aggregation propensity of the acid-unfolded state of
HypF-N at the site of mutation, as shown by the analysis
carried out with the ZYGGREGATOR (Fig. 2B),
AGGRESCAN (Fig. 2C) and PASTA (Fig. 2D) algorithms.
Similar results have been obtained using other algorithms
able to predict, similarly to the three softwares shown here,
the intrinsic aggregation propensity of a sequence from the
sequence, without considering the influence of secondary
and tertiary structure elements (Fernandez-Escamilla et al.,
2004; Yoon and Welsh, 2004; Tartaglia et al., 2005;
Galzitskaya et al., 2006; Maurer-Stroh et al., 2010; Chiti
et al., 2003). The selected mutations therefore represent valid
probes of the effect of changing the level of residual
a-helical structure in the regions of the sequence promoting
aggregation from the acid-unfolded state of HypF-N without
causing an increase of its intrinsic (sequence-based) aggrega-
tion propensity in the same regions. They will allow one to
assess whether or not the stabilisation of the residual
a-helical structure in the key regions of the acid-unfolded
state causes an increase in the aggregation rate of the protein.
We have also considered mutations that decrease the
a-helix content within the same two regions of the sequence
22–32 and 55–63. However, we considered this approach
technically more difficult as mutations of this type would
result also in a decrease of native state stability (i.e. in a
Fig. 1 Three-dimensional structure of native HypF-N (PDB ID 1GXU). The
positions of the mutated residues are shown (Gln31, Phe57 and Gln60).
These residues are all located in the two helices.
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decrease of DGF-U) and mutations of this type are known to
result in HypF-N insolubility during purification (Calloni
et al., 2005).
Acid-induced conformational transition of HypF-N variants
Acid-induced unfolding of wild-type and mutant HypF-N
was followed by intrinsic fluorescence and far-UV CD spec-
troscopy as probes for tertiary and secondary structure of the
protein, respectively (Fig. 3). Both optical probes show that
wild-type and mutant HypF-N are conformationally stable
from pH 7.0 to pH 3.5, with a loss of both tertiary and sec-
ondary structure occurring in the 3.5–2.0 pH range. In all
cases the unfolding transitions appear to be sharp and each
pair of plots obtained with the same HypF-N variants and
with the two probes are highly superimposable when normal-
ised to the fraction folded (data not shown). The lmax and
[u]222 data were fitted using a two-state transition model
(equation (1)). The pKa values of wild-type, Q31R, Q60R
and F57L/Q60R HypF-N were calculated as 2.94+ 0.06,
2.99+ 0.06, 2.92+ 0.06 and 2.86+ 0.09, respectively, from
lmax data. The pKa values were found to be 2.91+ 0.03,
2.96+ 0.03, 2.91+ 0.05 and 2.90+ 0.05, respectively, from
[u]222 data. For each HypF-N variant the pKa values calcu-
lated from lmax and [u]222 data were very similar. Overall,
the sharpness of the transitions, the good fitting of the two
state model to the experimental data and the finding that
each pair of the acid-unfolded curves give superimposable
plots and identical midpoints, within experimental error,
indicate that all the HypF-N variants studied here unfold at
low pH via an apparent two-state mechanism.
This analysis also shows that none of the mutants is stabil-
ised towards acid unfolding. However, the lmax and [u]222 of
all the acid-unfolded mutants in the post-transition regions
(i.e. at pH , 2.3) indicate the presence of higher levels of
secondary and tertiary structure, compared to the acid-
unfolded wild-type protein (Fig. 3A, B).
Conformational properties of HypF-N variants
In order to assess the secondary structure, tertiary structure,
exposure of hydrophobic clusters and compactness of the
HypF-N mutants in their acid-unfolded state relative to wild-
type protein, all the HypF-N variants were subjected to
Fig. 2 (A) a-Helical propensity (%) along the HypF-N sequence calculated using the AGADIR algorithm for the wild-type (solid line), Q31R (dashed line),
Q60R (dotted line) and F57L/Q60R (dotted-dashed line). (B–D) Intrinsic aggregation propensity of the various HypF-N mutants calculated at the site of
mutation using the ZYGGREGATOR (B), AGGRESCAN (C) and PASTA (D) algorithms. Each graph reports the predictions of the three mutants at the site of
mutation, beside the predictions of the wild-type sequence at the same site of mutation. When the algorithm required specific experimental conditions the
calculations were carried out at 258C, 50 mM ionic strength, pH 1.7.
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far-UV CD, intrinsic fluorescence, ANS fluorescence and
DLS measurements (Fig. 4). The far-UV CD spectrum of
wild-type HypF-N at pH 1.7 has a strong negative signal at
201 nm, with a negative shoulder at 220–235 nm, showing
that the protein retains elements of secondary structure at
low pH (Fig. 4A). The spectrum is consistent with that pre-
viously observed under the same conditions of pH, ionic
strength and temperature (Campioni et al., 2008; Calloni
et al., 2008). The far-UV CD spectra of the Q31R, Q60R
and F57L/Q60R mutants showed a negative CD band at 201,
203 and 206 nm, respectively (Fig. 4A). The red shift of the
band was also found to correspond to a more marked nega-
tive signal at 220–235 nm, with the F57L/Q60R mutant
exhibiting the most marked increment (Fig. 4A). These
observations suggest an increased amount of secondary struc-
ture in the acid-unfolded mutants compared to wild-type
HypF-N. The values of the total a-helical content in the acid
unfolded states of the various mutants, as estimated from the
[u]222 values (equation (3)), are 10.52+ 0.27, 10.90+ 0.20,
11.30+ 0.37 and 13.08+ 0.34% for the wild-type, Q31R,
Q60R and F57L/Q60R HypF-N, respectively, (Fig. 4A,
inset). Considering that the observed increases in total
a-helical content are the result of marked local increases at
mutated sites, the estimated increases at the sites of
mutation(s), calculated according to equation (4), is therefore
þ3.2+ 2.8% (Q31R, first helix), þ8.0+ 2.1% (Q60R,
second helix) and þ26.1+ 4.4% (F57L/Q60R, second
helix), in good agreement with the predictions by AGADIR.
The intrinsic fluorescence emission spectra of the three
mutants of HypF-N in their acid-unfolded state at pH 1.7
were significantly different from that of the wild-type protein
in both the overall fluorescence intensity and lmax values
(Fig. 4B). The Q31R and Q60R mutants showed 10%
decrease in total fluorescence intensity compared to wild-
type protein. By contrast, the total fluorescence intensity of
the F57L/Q60R mutant was found to be 16% higher to
that of the wild-type protein. The lmax values of all the
mutant proteins are blue-shifted compared to that of the wild-
type protein (Fig. 4B, inset). The Q31R and Q60R showed
blue-shifts of ca. 2 nm, while the double mutant showed a
blue shift of ca. 4 nm (Fig. 4B, inset). This indicates that the
tryptophan residues are buried to a greater extent in the acid-
unfolded mutants compared to the acid-unfolded state of
wild-type protein. The degree of tryptophan burial appears to
increase from the wild-type protein to the double F57L/
Q60R mutant, following a trend similar to that observed for
the increase of a-helical content.
ANS preferentially binds to solvent-accessible hydro-
phobic clusters in a protein, producing a marked increase in
its fluorescence emission intensity and a large blue shift of
its lmax value, typically from 520 nm to 480 nm, when com-
pared with free ANS in water (Semisotnov et al., 1991).
Changes in ANS fluorescence parameters can thus efficiently
detect structural alterations of a protein following changes of
solution conditions or mutation. Figure 4C shows the fluor-
escence emission spectra of ANS in the presence of the
various HypF-N variants at pH 1.7 (the free ANS spectrum
was subtracted from all spectra). The ANS fluorescence
appears to be enhanced by 3-fold when the wild-type protein
is present, 5-fold for the Q31R and Q60R mutants and 8-fold
for the F57L/Q60R double mutant. For all the HypF-N var-
iants, the lmax is also blue-shifted from 520 nm (free ANS)
to 485–490 nm. Precisely, the lmax values for the wild-type,
Q31R, Q60R and F57L/Q60R are 489.7+ 2.1, 490.3+ 2.4,
485.8+ 1.6 and 486.6+ 2.3, respectively (Fig. 4C, inset).
The enhanced ANS fluorescence and further blue-shift of the
lmax value indicates an increase in hydrophobic surface area
in the mutants relative to the wild-type protein. These data,
together with the intrinsic fluorescence data suggest that the
HypF-N mutants adopt, in their acid-unfolded state, a struc-
tural ensemble that contains a more consolidated, yet
solvent-exposed, hydrophobic core than the wild-type
protein.
The apparent hydrodynamic diameters of wild-type and
mutant proteins in their acid-unfolded state at pH 1.7 were
determined with DLS (Fig. 4D). These were found to be
5.7+ 0.2, 5.5+ 0.1, 5.5+ 0.1 and 5.2+ 0.2 nm for wild-
type, Q31R, Q60R and F57L/Q60R HypF-N, respectively
(Fig. 4D, inset). The result obtained for the wild-type protein
is again in agreement with previously reported data
Fig. 3 Acid-induced unfolding at equilibrium of HypF-N variants monitored
by (A) the wavelength of maximum fluorescence emission (lmax) and (B)
mean residue ellipticity at 222 nm ([u]222). Data and lines of the best fit refer
to wild-type (—†—), Q31R (–-A–-), Q60R (...O...) and F57L/Q60R
(–.–W–.–) HypF-N. The lines were obtained by fitting the data to a
two-state model (equation (1)). Conditions were 50 mM total ionic strength,
2 mM DTT, 258C.
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(Campioni et al., 2008). The increase in compactness
observed with DLS for the acid-denatured HypF-N mutants
at pH 1.7 is consistent with the increase of tertiary structure
monitored by intrinsic and ANS-derived fluorescence.
Overall, following the analysis carried out with far-UV
CD, intrinsic fluorescence, ANS fluorescence and DLS, the
a-helical content of the acid-unfolded state of HypF-N
appears to increase from the wild-type to the mutants at the
corresponding sites of mutation(s), with such an increase cor-
relating with burial of tryptophan residues, consolidation of
the hydrophobic core and compactness. In this trend the
F57L/Q60R double mutant features the most remarkable
changes of all the measured parameters.
Conformational stability of HypF-N
We next investigated the conformational stabilities of the
HypF-N variants by acquiring urea-induced unfolding curves
at equilibrium at pH 7.0 and using far-UV CD as an optical
probe to monitor unfolding. The aim of this analysis was not
to evaluate the conformational stability of the native state for
the 4 variants studied here, which is beyond the scope of the
present work. It is rather to determine the cooperativity of
the unfolding transition (i.e. the m values), which provides
information on the differences of solvent-accessible surface
area (DASA) on unfolding and, hence, on the compactness
of the urea-unfolded state of the four analysed variants
(Myers et al., 1995).
The urea-induced unfolding transitions of all the HypF-N
variants at pH 7.0 were found to be single-step processes
(Fig. 5A). The transitions were also found to be completely
reversible for all the mutants. By fitting the experimental
data to a two-state model (equation (2)) the values of
DGH2O, m and midpoint of unfolding transition (Cm) were
determined for all the studied HypF-N variants. The analysis
yielded DGH2O and m values of 33.4+ 3.4 kJ mol21 and
7.3+ 0.7 for wild-type HypF-N, which are in good agree-
ment with those previously determined (Calloni et al., 2003,
2005). The midpoint of the unfolding transition of the
mutants was not found to be higher than that of wild type.
This was found to be 4.58+ 0.06, 4.56+ 0.08, 4.54+ 0.07
and 4.42+ 0.08 M for wild type, Q31R, Q60R and F57L/
Q60R, respectively. The m values for the mutants were
observed to be lower than that of the wild-type protein:
7.3+ 0.3, 6.2+ 0.2, 6.6+ 0.2 and 6.2+ 0.2 for wild type,
Q31R, Q60R and F57L/Q60R, respectively (Fig. 5A, inset).
On the other hand, the DGH2O values were calculated to be
33.4+ 3.4, 28.3+ 2.7, 29.9+ 3.0 and 27.6+ 3.8 kJ mol21
for wild type, Q31R, Q60R and F57L/Q60R HypF-N,
respectively. The decrease in DGH2O values for the mutants
compared to the wild-type protein are due to the low m
Fig. 4 Far-UV CD spectra (A), intrinsic fluorescence emission spectra (B), ANS fluorescence emission spectra (C) and size distributions obtained with DLS
(D) for the HypF-N variants. The data refer to wild-type (—), Q31R (– –), Q60R (.....) and F57L/Q60R (–.–.–) HypF-N. All measurements were carried out
in 20 mM TFA, 50 mM ionic strength, 2 mM DTT, pH 1.7, 258C. In each panel the inset displays the values of a specific parameter, for the four analysed
HypF-N variants extracted from the spectra shown in the corresponding main panel. In (A), inset, the numbers in brackets indicate the changes in a-helical
content at the site of mutation relative to the wild-type sequence. Error bars indicate standard errors.
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values displayed by the mutants. The analysis therefore
shows that the mutations result in an increased compactness
of the urea-unfolded state.
We repeated the experiments at pH 1.7, thus under condition
in which the four HypF-N variants populate initially, in the
absence of urea, the acid-unfolded state. This set of exper-
iments allowed the conformational stability of the acid-
unfolded state to be evaluated for the four variants, particularly
by determining the urea concentration at which the transition
from the acid-unfolded state to the fully unfolded state in urea
has occurred to 50%. All the mutants appeared to unfold in a
non-cooperative manner (Fig. 5B). The mid-points of the tran-
sition for wild type, Q31R, Q60R and F57L/Q60R HypF-N
were calculated to be 1.81+0.08, 1.94+0.06, 1.98+0.15
and 2.69+0.15 M, respectively (Fig. 5B, inset). Interestingly,
the midpoint of the transition was found to correlate with the
increase of a-helical content, consolidation of hydrophobic
core and compactness in the acid-unfolded variants.
Kinetics of aggregation of HypF-N mutants
Wild-type HypF-N, at a protein concentration of 0.5 mg/ml
(48 mM), was found to aggregate in 20 mM trifluoroacetic
acid (TFA), 330 mM NaCl, 2 mM DTT, pH 1.7, 258C
(Campioni et al., 2008). Aggregation was detected as an
exponential increase in ThT fluorescence and as the for-
mation of small spherical aggregates of 3–4 nm diameter, as
detected with AFM (Campioni et al., 2008; Calloni et al.,
2008). Such protein aggregates convert subsequently into
protofibrils formed by the association of the beads after a
few weeks (Campioni et al., 2008).
In order to assess whether the increase of secondary and
tertiary structure observed in the mutants causes a change in
the aggregation rate, the aggregation kinetics of the HypF-N
variants were monitored by ThT fluorescence under the
aforementioned conditions. Figure 6 reports the time courses
of ThT fluorescence for all the HypF-N variants, each ana-
lysed 3–4 times. The ThT traces were found to be reproduci-
ble for the same protein variant and were satisfactorily fitted
to a single-exponential function (equation (5)). The resulting
aggregation rate constant (kagg) values show that the mutants
aggregate with a rate similar to that of the wild-type protein
(Fig. 6D, inset). The single and double mutants involving
a-helix 2 (Q60R and F57L/Q60R) were found to aggregate
with a rate slightly higher than the wild-type protein.
However, the rates of the two mutants were similar and did
not correlate with the difference of a-helical and tertiary
structure observed between them with all structural probes.
More generally, no correlation was observed between the
kagg values and the a-helical content, or tertiary structure
content, in the protein variants analysed here.
We also analysed the morphologies of the aggregates
formed after 2 h with AFM (Fig. 7). The oligomers formed
by wild-type HypF-N appear to have spherical or discoid
shape and to have a height of 2.8+0.4 nm (Fig. 7A, F), in
agreement with previous reports (Campioni et al., 2008,
2010; Calloni et al., 2008). The oligomers formed by the
three mutants appear to be similar in size and height
(Fig. 7B–D, F), indicating that the variants analysed here
and the wild-type protein form the same type of oligomeric
structures.
Discussion
a-Helical stability and aggregation rate are uncorrelated in
highly dynamic states
HypF-N is a 91 residue, a/b protein belonging to the
acylphosphatase-like structural family and having a
ferredoxin-like fold with two a-helices packed against a
five-stranded b-sheet (Rosano et al., 2002). The formation of
a partially folded state is a key event in the aggregation
pathway of this protein in vitro, even under mild destabilis-
ing conditions in which the folded state is by far the predo-
minant species (Chiti et al., 2001; Marcon et al., 2005).
Under acidic conditions HypF-N unfolds into a partially
folded state with all the characteristics of pre-molten globule
state; such a conformational state was shown to be mono-
meric, possess a significant level of secondary structure and
display the presence of a rudimental core, as revealed by
far-UV CD, intrinsic fluorescence, ANS binding and DLS
(Campioni et al., 2008). NMR spectroscopy allowed one to
Fig. 5 Urea-induced unfolding at equilibrium of HypF-N variants in their
native states at pH 7.0 (A) and acid-unfolded states at pH 1.7 (B), monitored
by mean residue ellipticity at 222 nm. The lines through the data points were
obtained by fitting the data to a two-state model (equation (2)). The data and
the lines of best fit refer to WT (—†—), Q31R (–-A–-), Q60R (...O...) and
F57L/Q60R (–.–W–.–) HypF-N. The insets show the m values obtained at
pH 7.0 (A) and the Cm values measured at pH 1.7 (B) of the HypF-N
variants resulting from the procedure of best fitting.
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identify the regions of the sequence that are most structured,
albeit flexible, in the acid-denatured state (Calloni et al.,
2008). It was found that the regions of the sequence encom-
passing residues 23234, 56264 and 81282, corresponding
to the three major hydrophobic regions of the sequence, form
interactions between them, although such interactions are
flexible and in slow exchange (Calloni et al., 2008).
Moreover, the regions of sequence encompassing residues
26230, 56261 and 46249 adopt a partially formed
a-helical structure. Hence, it appears that the first two of
such three regions, which also adopt a-helical structure in
the native state, participate to the flexible hydrophobic core
and adopt a-helical structure in the acid-denatured state of
HypF-N.
The data presented in this paper show that the increase in
a-helical propensity at the level of either a-helix in the acid-
denatured state of HypF-N results in an increased amount of
a-helical structure (Fig. 4A). Such an increase is small if cal-
culated on the overall sequence, but is marked at the site(s)
of mutation, amounting to þ26.1+ 4.4% in the double
mutant in a scale from 0% (no helix) to 100% (fully formed
helix). The stabilisation of either a-helix also results in a
consolidation of the hydrophobic core, as detected using
intrinsic and ANS-derived fluorescence measurements
(Fig. 4B, C), and in a compaction of the denatured ensemble,
as indicated by DLS and measurements of the m value in
urea-unfolding at equilibrium (Figs. 4D, 5A). Since the two
regions of the sequence subjected to mutation in this study
participate to both the a-helical structure and the formation
of the rudimental hydrophobic core, it is likely that the con-
solidation of the amphipathic helices also brings a positive
contribution to the consolidation of the hydrophobic core and
the overall compactness of the acid-denatured state.
The acid-denatured state of wild-type HypF-N obtained at
pH 1.7 was known to convert, at 350 mM ionic strength on
the timescale of a few hours, into spherical oligomers with a
height of ca. 3 nm, with a large amount of b-sheet structure
and an ability to bind ThT (Campioni et al., 2008, 2010;
Calloni et al., 2008). The mutants with stabilised a-helical
structure used in this study were found to aggregate into
similar spherical oligomers, as shown by AFM (Fig. 7), with
a rate that did not appear to be significantly different from
that of the wild-type protein, as shown by the ThT fluor-
escence time courses (Fig. 6). This indicates that the consoli-
dation of a-helical structure in the acid-denatured state of
HypF-N does not lead to a significant change of the
Fig. 6 Aggregation time courses of HypF-N variants, monitored with ThT fluorescence, in 20 mM TFA, 330 mM NaCl, 2 mM DTT, pH 1.7, 258C. The traces
refer to wild-type (A), Q31R (B), Q60R (C) and F57L/Q60R (D). Each panel reports multiple traces for the same protein variant, which are differentiated by
symbol and line type. In all cases data are reported as the ratio of ThT fluorescence in the presence (F) and absence (F0) of protein as a function of time. The
lines of best fit through the data points were obtained by fitting the data with a single exponential function (equation (5)). The inset in (D) shows the
aggregation rate constant (kagg) values obtained from the procedure of best fitting for all HypF-N variants: the data and associated experimental errors are
means and standard deviations, respectively.
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aggregation rate of the protein from such a conformational
state. This result is remarkable when considering that the two
regions subjected to mutation not just retain a-helical struc-
ture in the acid-denatured state of HypF-N, but also are
shown to be involved in the rate-determining steps of the
conversion of this state into oligomers as well as in the struc-
tural core of the resulting aggregates (Calloni et al., 2008;
Campioni et al., 2010).
Previous attempts to investigate the role of a-helical struc-
ture contained in unstructured states on amyloid formation
have relied on the induction of a-helical structure by remark-
able changes of solution conditions or by the introduction of
non-conservative mutations. Both changes, however, also led
to alterations of other variables that are known to play an
important role in protein aggregation and cannot therefore
represent valid perturbations to specifically investigate the
role of a-helical structure (see the Introduction section). In
this study protein engineering has been carried out to target
only the propensity of forming a-helical structure: we have
further increased the a-helical propensity of partially formed
a-helices while maintaining the same solution conditions
and minimising the alterations of the physicochemical,
sequence-specific parameters involved in protein aggregation
(Fig. 2).
In our previous study it was shown that the regions of the
HypF-N sequence that promote the conversion of the acid-
denatured state into ThT-binding and b-sheet containing oli-
gomers coincide with the peaks of the aggregation propensity
profile, meaning that they have the sequence-based physico-
chemical parameters appropriate for triggering amyloid for-
mation (Calloni et al., 2008). No correlation was found
between such stretches and those forming (or non-forming)
secondary or tertiary structure in the acid-denatured state
(Calloni et al., 2008). The absence of a significant effect of
the stability of a-helical structure on the aggregation of acid-
denatured HypF-N reinforces the idea that the aggregation of
highly dynamic conformational states into amyloid is not
determined significantly by the non-persistent residual struc-
ture present in the initial monomeric state, but by amyloido-
genic segments of the sequence that have a sufficiently high
intrinsic aggregation propensity, which is determined on the
basis of parameters such as hydrophobicity, b-sheet
propensity and charge.
The importance of the stability and location of a-helical
structure
A similar study was performed on the TFE-denatured state of
human muscle acylphosphatase (mAcP); similarly to the case
presented here, the a-helical propensity was increased in
both regions adopting a-helical structure in the native state
using mutations that did not alter significantly the intrinsic
aggregation propensity (Taddei et al., 2001). The mutations
increasing the a-helical propensity of the first helix, which is
also involved in aggregation, led to a significant deceleration
of the aggregation process. The subject of that study was,
however, a TFE-denatured state, where the two a-helices
were stabilised to a level similar to, or even more than, the
native state. In other studies it was noticed that an excessive
content of lipid membranes induces an over-stabilisation of
the a-helical structure of IAPP, causing a substantial inhi-
bition of amyloid formation by this peptide (Jayasinghe and
Langen, 2005; Apostolidou et al., 2008). Along the same
lines, it has been found that one of the strategies used by
evolution to neutralise amyloidogenic stretches within nor-
mally folded proteins is to hide them into a-helical segments
(Tzotzos and Doig, 2010; Kallberg et al., 2001). A distinc-
tion has to be made, therefore, between stable (persistently
formed) and dynamic, partially formed (non-persistently
formed) a-helical structures. The amyloidogenic potential of
a sequence segment with a high intrinsic aggregation propen-
sity can be decreased dramatically by adopting a stable
a-helical structure, because the a-helical structure has to be
unfolded to initiate aggregation. Strategies aimed at stabilis-
ing the helix further are likely to be effective in inhibiting
aggregation in this case. On the other hand, unstable and par-
tially formed helices are unlikely to represent an effective
defence against the aggregation because the helix exposes its
residues regularly during the structural fluctuations revealing
the aggregation potential of its sequence. Increasing the
a-helical propensity of such stretches does not inhibit aggre-
gation in this case, unless the increase in a-helical propensity
allows the helix to pass from the first to the second regime.
In other studies it has been proposed that the formation of
amphipathic a-helices in initially disordered peptides can be
a productive event for aggregation, provided the newly
formed a-helices involve regions of the sequence that are not
amyloidogenic (Abedini and Raleigh, 2009). Under these cir-
cumstances, the newly formed a-helices from different
peptide molecules can form interactions via their hydro-
phobic surfaces, thus giving rise to oligomers where the
unstructured amyloidogenic sequences are spatially closer. In
such an oligomer the unstructured amyloidogenic stretches
have an increased frequency of collisions, resulting into an
acceleration of the formation of the cross-b structure motif
Fig. 7 AFM images of wild-type (A), Q31R (B), Q60R (C) and F57L/Q60R
(D) HypF-N (scan size: 1 mm). All variants were pre-incubated for 2 h in 20
mM TFA, 330 mM NaCl, 2 mM DTT, pH 1.7, 258C. (E) Example of a Z
profile used to measure oligomer height. (F) Oligomer height (mean+
standard error) of wild-type (n ¼ 12), Q31R (n ¼ 10), Q60R (n ¼ 14) and
F57L/Q60R (n ¼ 17) HypF-N.
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of amyloid (Abedini and Raleigh, 2009). In the study pre-
sented here, the stabilised a-helical structure involves
regions of the sequence that are also amyloidogenic, thus
representing a scenario distinct from that proposed previously
for IAPP.
As a conclusion of our and other studies it appears that
stabilisation of a-helical structure can cause an acceleration
of the aggregation process depending on the initial stability
and location of the a-helices. In particular the effect can
vary if the stabilised helices are (i) in non-amyloidogenic
stretches of initially unstructured peptides (accelerating
effect), (ii) in amyloidogenic stretches of initially unstruc-
tured peptides (no effect) or (iii) in amyloidogenic stretches
of initially stable helices (decelerating effect).
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